China News Service, May 5 (Xinhua) According to Taiwan's "China Times News Network" report, Taiwan's local epidemic broke out, and the supply and price of rapid screening reagents caused controversy.

Yang Zhiliang, the former "Director of Health" of the Taiwan authorities, said that his application to the "Ministry of Health and Welfare" to donate 10 million doses of rapid screening reagents was blocked, so he was mentally prepared to give up the deposit.

The authorities spent 10 billion yuan (NTD, the same below) to buy 100 million doses of rapid screening reagents, and then sold one dose to the public for 100 yuan under the real-name system. This is basically "making money from the epidemic". This bullying of the whole people makes him Can't help but question: "What's the use of so much money?"

  Yang Zhiliang attended an academic event on the 4th. After the meeting, he was interviewed by the media and pointed out that the current policy of the authorities is to "use the epidemic to make money and bully the whole people" as an appeal. 100 million doses of quick-screening reagents, and then a real-name dose of 100 yuan, and tossing people to line up to buy it, "Isn't it 20 billion yuan to go back and forth? What is the use of so much money?"

  Yang Zhiliang gave an example. Most Taiwanese do not know that rapid screening reagents have been commercialized in some places, so they can be purchased at low prices.

He asked for the full commercialization of rapid screening reagents, just like masks are now.

  Not only that, Yang Zhiliang revealed that his application to the "Ministry of Health and Welfare" for donation of 10 million doses of rapid screening reagents has been blocked. These batches of rapid screening reagents are stored in a port very close to Taiwan, and they will arrive in Taiwan soon by plane. , but he was deliberately blocked by the "Ministry of Health and Welfare", so he was mentally prepared to give up the deposit.

As for how much the deposit is and which port to store, he needs to keep it first.